Home » Topics » BioWorld Science

BioWorld Science
RSS

Celgene updates milestones of fourth quarter 2017

Jan. 31, 2018

Corbus Pharmaceuticals receives award to support phase IIb study of lenabasum

Jan. 31, 2018

Artelo Biosciences to evaluate anticancer potential of drug from NEOMED Institute

Jan. 31, 2018

FDA gives orphan drug status to Dauntless Pharmaceuticals' DP-1038 for acromegaly

Jan. 31, 2018

Versican biomarker shown to be prognostic in patients with pancreatic neuroendocrine tumors

Jan. 31, 2018

Interim data from phase I/II trial of LiPlaCis in heavily pretreated breast cancer

Jan. 31, 2018

Eisai and Boston University enter Alzheimer's research collaboration

Jan. 31, 2018

EMA committee recommends approval of biosimilar insulin glargine Semglee

Jan. 31, 2018

FDA places U.S. studies of BPX-501 on clinical hold

Jan. 31, 2018

Aravive Biologics and WuXi Biologics to expand collaboration following IND filing for AVB-S6-500

Jan. 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...